Members of the Joint Economic Committee question Treasury Secretary Timothy Geithner on financial reform.
David Spika, of WHG Funds, and Bill Smead, of Smead Capital Mgmt., share their investment strategies and stock picks.
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Dr. Steven Nissen, chairman of the Department of Cardiovascular Medicine at ...
A new study is putting Merck's cholesterol drugs under pressure today, reports CNBC's Mike Huckman, with Ken Frazier, Merck Global Human Hea...
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Barbara Ryan, pharma analyst at Deutsche Bank Securities, shares her reactio...
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.
Posts |
COMPANY : Abbott Laboratories
24 Nov 2009
Here's our Fast Money Final Trade... Read More
20 Nov 2009
Earlier this week I reported that Dr... Read More
19 Nov 2009
If you’re looking for stocks to buy and hold, here’s a strategy as well as a few names you should know about.... Read More
17 Nov 2009
Stocks opened lower on Tuesday, after a sharp rally in the prior session... Read More
16 Nov 2009
Live TV is best when things are happening and news is breaking right now... Read More
News |
COMPANY : Abbott Laboratories
Monday, 16 Nov 2009
About CNBC | Site Map | Privacy Policy | Terms of Service | Video Reprints | Advertise | Help | Contact
Partners: AOL Money | BloggingStocks.com
Partners: AOL Money | BloggingStocks.com
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2009 CNBC, Inc. All Rights Reserved.
A Division of NBC Universal
